Pharmacopsychiatry
Utilizing Machine Learning to Forecast 3-Month Remission Outcomes in Bipolar Disorder Patients Treated with Lithium.
Alessandro Cuomo, Despoina Koukouna, Simone Pardossi, Mario Pinzi, Caterina Pierini, Maria Beatrice Rescalli, Andrea Fagiolini
Published: 202510.1055/a-2751-7163
Abstract
Lithium remains a first-line mood stabilizer for bipolar disorder; yet, only a subset of patients achieves symptomatic remission. Early prediction of treatment response could guide personalized management. In this study, we leveraged machine learning…
Preview only. Read the full abstract at the source